We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+5.52%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$5.65B
AUM Growth
+$471M
(+9.1%)
Cap. Flow
+$283M
Cap. Flow
% of AUM
5.01%
Top 10 Holdings %
Top 10 Hldgs %
17.56%
Holding
1,507
New
476
Increased
192
Reduced
202
Closed
448
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$14.4M |
| 2 |
argenx
ARGX
|
+$13.4M |
| 3 |
Compañía de Minas Buenaventura
BVN
|
+$13.1M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$11.3M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KraneShares CSI China Internet ETF
KWEB
|
+$16.7M |
| 2 |
Sabre
SABR
|
+$12.5M |
| 3 |
UBS Group
UBS
|
+$10.2M |
| 4 |
Walt Disney
DIS
|
+$9.97M |
| 5 |
CBL
CBL Properties
CBL
|
+$7.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.56% |
| 2 | Technology | 1.89% |
| 3 | Consumer Discretionary | 0.9% |
| 4 | Communication Services | 0.87% |
| 5 | Industrials | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
4D Molecular Therapeutics
FDMT
$532M
| $216K | ﹤0.01% |
+11,944
| New | +$220K |
|
927
PUT
Myriad Genetics
MYGN
$270M
| $216K | ﹤0.01% |
+9,300
| New | +$203K |
|
|
DRRX
928
PUT
DELISTED
DURECT Corp
DRRX
| $215K | ﹤0.01% |
+43,400
| New | +$220K |
|
|
EBIX
929
PUT
DELISTED
Ebix Inc
EBIX
| $214K | ﹤0.01% |
+8,500
| New | +$159K |
|
|
AIV
930
Aimco
AIV
$387M
| $213K | ﹤0.01% |
25,000
-122,670
| -83% | -$998K |
|
931
PUT
Immersion
IMMR
$251M
| $212K | ﹤0.01% |
+30,000
| New | +$222K |
|
932
CALL
Iovance Biotherapeutics
IOVA
$1.82B
| $211K | ﹤0.01% |
30,000
| – | – |
|
|
933
PUT
Iovance Biotherapeutics
IOVA
$1.82B
| $211K | ﹤0.01% |
30,000
| – | – |
|
934
CALL
Ceragon Networks
CRNT
$197M
| $206K | ﹤0.01% |
+98,000
| New | +$181K |
|
|
SILV
935
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $205K | ﹤0.01% |
+35,000
| New | +$230K |
|
936
Clarivate
CLVT
$1.27B
| $205K | ﹤0.01% |
21,500
+6,947
| +48% | +$58.9K |
|
937
PUT
Uranium Energy
UEC
$4.75B
| $204K | ﹤0.01% |
+60,000
| New | +$171K |
|
938
Eldorado Gold
EGO
$7.87B
| $202K | ﹤0.01% |
+20,000
| New | +$212K |
|
939
Progyny
PGNY
$2.44B
| $198K | ﹤0.01% |
5,045
+2,000
| +66% | +$72.2K |
|
940
Pultegroup
PHM
$24.1B
| $194K | ﹤0.01% |
+2,500
| New | +$169K |
|
|
CGC
941
PUT
Canopy Growth
CGC
$387M
| $194K | ﹤0.01% |
+50,000
| New | +$525K |
|
942
Upwork
UPWK
$1.13B
| $185K | ﹤0.01% |
+19,772
| New | +$179K |
|
943
Burford Capital
BUR
$903M
| $183K | ﹤0.01% |
+15,000
| New | +$194K |
|
944
Sigma Lithium
SGML
$1.11B
| $181K | ﹤0.01% |
4,500
-3,269
| -42% | -$125K |
|
945
Editas Medicine
EDIT
$396M
| $179K | ﹤0.01% |
21,700
+10,000
| +85% | +$87.1K |
|
|
ACCD
946
DELISTED
Accolade Inc
ACCD
| $175K | ﹤0.01% |
13,000
+12,000
| +1,200% | +$156K |
|
|
QUOT
947
DELISTED
Quotient Technology Inc
QUOT
| $173K | ﹤0.01% |
45,000
| – | – |
|
948
ProFrac Holding
ACDC
$731M
| $172K | ﹤0.01% |
+15,406
| New | +$182K |
|
949
PUT
Xponential Fitness
XPOF
$273M
| $166K | ﹤0.01% |
+9,600
| New | +$272K |
|
950
Antero Midstream
AM
$10.4B
| $165K | ﹤0.01% |
+14,250
| New | +$151K |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2023 Portfolio in Review
As of Q2 2023, Caption Management held 1,507 positions worth $5.65B, up 9.1% from $5.18B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Caption Management deployed $283M of net new capital in Q2 2023, opening 476 new positions and adding to 192 existing holdings. Its largest new stake was Lockheed Martin: 31,000 shares worth $14.3M.
By sector, the portfolio is most concentrated in Healthcare at 2.6% of assets, up from 2% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Sabre, an estimated $12.5M trimmed.
- Caption Management's largest Q2 2023 buy was Lockheed Martin: 31,000 shares worth $14.3M.
- Caption Management added most to State Street SPDR S&P Biotech ETF in Q2 2023, an estimated $11M increase.
- Caption Management's biggest Q2 2023 reduction was Sabre, cutting an estimated $12.5M.
- Caption Management fully exited KraneShares CSI China Internet ETF in Q2 2023, selling an estimated $16.7M.
- Caption Management's ten largest holdings make up 18% of its $5.65B portfolio in Q2 2023.
- Caption Management opened 476 new positions and closed 448 in Q2 2023.
- Caption Management's portfolio value rose 9.1% quarter-over-quarter to $5.65B.
Based on Caption Management's 13F filing for Q2 2023, filed 14 Aug 2023.